Advance in Process Optimization and Control with NMR as Process Analytical Technology (PAT)
Intro
In today's competitive pharmaceutical landscape, leveraging advanced technologies such as Nuclear Magnetic Resonance (NMR) and Process Analytical Technology (PAT) is crucial. These innovations are driving significant improvements in processing efficiency and product quality. As the industry moves towards digital manufacturing and embraces Quality by Design (QbD) principles, integrating these technologies becomes essential for maintaining a competitive edge and ensuring regulatory compliance.
Webinar Overview
Join us for an insightful webinar where industry experts will delve into the transformative impact of NMR and PAT on processing control. This session will cover the latest technological advancements, practical applications, and case studies demonstrating the benefits of integrating these tools into your processing workflows. Attendees will gain a comprehensive understanding of how NMR and PAT can optimize process control, enhance product consistency, and ensure regulatory compliance. We will also discuss the advantages, challenges, and future developments of these innovative technologies, focusing on the transition to digital manufacturing.
Tuesday, 13 May 2025
5:00 PM CET | 12:00 PM EDT
What to expect
Join in-depth presentations on NMR, PAT, and process applications, covering their roles in modern quality control from early development to manufacturing. Explore real-world case studies that demonstrate how PAT technologies enhance process understanding and efficiency. Engage in an interactive Q&A session with industry experts to discuss challenges and innovative solutions.
Key Learning Topics
- Enhanced Process Control: Understand how NMR and PAT improve monitoring and control in processes, ensuring efficiency and reliability.
- Quality Assurance: Discover strategies to maintain product quality and regulatory compliance throughout development and manufacturing.
- Innovative Applications: Explore advanced applications of NMR and PAT in pharmaceutical API production, driving innovation and improving process analytical capabilities.
Who Should Attend
This webinar is designed for bioprocess engineers, quality assurance professionals, regulatory affairs specialists, and anyone engaged in pharmaceutical manufacturing and development. It is ideal for those seeking to enhance process control, ensure product quality, and explore innovative applications of NMR and PAT technology.
Speakers
Martin Warman
Director of Martin Warman Consultancy Ltd and Associate Member at CPACT
Martin is the Director of Martin Warman Consultancy Ltd.He has over 25 years of experience, having previously led the Global PAT Development Team at Pfizer as well as leading the Vertex PAT and Continuous Manufacturing teams.
Martin is an Associate Member at CPACT and leads the Emerging Measurement Technology focus group.
Gabriella Gerzon
PhD Candidate, York University, Toronto, Canada (Sanofi Collaboration)
Gabriella Gerzon is currently a PhD student in the Biology Department at York University, Toronto, Canada. Gabriella received her MSc. in Biological Sciences from York University, and her studies focused on mechanisms of epigenetic signaling in response to DNA damage. Currently, Gabriella’s research is in collaboration with Sanofi Pasteur Ltd. and focuses on the development of various analytical techniques to implement PAT solutions for bioprocess monitoring.
Alejandro Bara-Estaún, PhD
Solution Product Manager for (bio)Process Analytical Technology, Bruker Biospin
Alejandro Bara Estaun obtained his Ph.D. in Inorganic Chemistry at the University of Bath (UK) in collaboration with Bristol University and Evonik (Germany). He then undertook a two-year postdoctoral position at Bruker, leading the PIPAc project in collaboration with Alysohpil, Novalix, and De Dietrich. Recently, he transitioned into the role of Solution Product Manager for (bio)Process and Process Analytical Technology within Bruker’s Biopharma and Applied (BPA) division.
Moderator
Matteo Pennestri, Ph. D.
Team Leader, PAT and Automation, Bruker BioSpin
Matteo Pennestri obtained his Ph.D. in Biophysical methods at the University of Tor Vergata Rome (collaboration with Merck Sharp and Dohme). Then he moved as NMR spectroscopist in the pharmaceutical industry (MSD and EISAI). After experiencing the pharma sector, he joined as application scientist Agilent Technologies first (ex. Varian) and Bruker afterwards. After joining the Bruker Pharma unit as NMR specialist and Product Manager he recently become Team Leader PAT for Automation and Process Analytical Technology.